Soma Pharmacy Blognews

MRI Availability Appears to Increase Low Back Surgery (CME/CE)
Patients with low back pain are more likely to have surgery if they live in an area with more magnetic resonance imaging (MRI) machines, researchers say.

Tylenol May Weaken Infant Vaccines
Acetaminophen (e.g., Tylenol) can prevent vaccine-related fever in infants — but new data suggest it weakens vaccine-induced immunity.

Daily Pot Smokers Court Health Risks
Marijuana smokers who take up the habit in their teens, as well as those who smoke daily or nearly every day, are at the greatest risk for dependence and other ill health effects, according to a new review of marijuana use worldwide by Australian researchers.

Expert Panel: Smoking Bans Save Lives
A major report by the Institute of Medicine shows that secondhand smoke causes heart attacks and smoking bans save lives.

Placebo Effect May Help Treat Pain
The “placebo effect” may help treat pain, German researchers report in the journal Science.

Sweet, Sour, Salty… and Fizzy?
Carbonated drinks may do more than tickle and fizz; they also trigger taste receptor cells, a new study shows.

HPV Vaccine Cuts Cases of Genital Warts
Use of human papillomavirus (HPV) vaccine has led to rapid declines in cases of genital warts in Australia, a study shows.

Access Pharmaceuticals’ update on its European commercial launch of Mugard
ACCESS PHARMACEUTICALS, INC. today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a debilitating side effect of radiation treatment and chemotherapy.

FDA launches web page with information on how to dispose of certain drugs
The U.S. Food and Drug Administration today launched a Web page for consumers with information on how to dispose of certain drugs, including several high-potency opioids and other selected controlled substances.

Mylan Pharmaceuticals receives approval for Topiramate Capsules
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Topiramate Capsules (Sprinkle), 15 mg and 25 mg.